RxDoctor Payments Data

Tariq Mughal

Hematology & Oncology · Worcester, MANPI 1316914773

Payments from drug & device makers

$292,456in general payments, 2019–2025

Across 118 payments — averaging $2478.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stemline Therapeutics Inc.$148K
  • Sanofi$142K
  • Athenex Pharmaceutical Division, LLC$3K
  • Karyopharm Therapeutics Inc.$271
  • Bristol Myers Squibb$128
  • Incyte Corporation$37

What the payments were for

  • Consulting fees$77,19126%
  • Speaking & faculty fees$83,86129%
  • Travel & lodging$129,42644%
  • Food & beverage$1,9781%

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stemline Therapeutics Inc.10$147,934
Sanofi98$141,564
Athenex Pharmaceutical Division, LLC6$2,522
Karyopharm Therapeutics Inc.2$271
Bristol Myers Squibb1$128
Incyte Corporation1$37

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$292,456 in reported general payments places this provider in the 70th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts

Other hematology & oncology in Worcester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →